Based in Colorado, ClinOne is a clinical trial management platform that can be used by research sites throughout the clinical trial process. The platform focuses on three key areas: 1) raising awareness about clinical trials with patients and physicians, 2) providing information to patients and enabling e-consent, and 3) making it easier for patients to take part through decentralized clinical trials, regular reminders for self-medication, and connectivity with transport solutions. The company claims to have the fastest deployment time in the industry, between 2 to 8 weeks. ClinOne noted that as of November 2023, its platform was being used across 60 countries by more than 80 sponsors, Contract Research Organizations (CROs), and site networks.
Key customers and partnerships
As of May 2022, ClinOne was reported to have a customer base of over 50, including Moderna, AstraZeneca, Astellas, Ipsen, and Eisai.
In June 2019, the company announced a partnership with Uber Health, providing patients with transportation solutions for visits to research sites during a clinical trial.
Funding and financials
The company reported that its revenue grew 125% YoY in 2021 and 15 new customers were added during the year.
In November 2023 ClinOne raised USD 2 million in a Series A extension round, supporting the initial Series A funding round held in April . The extension round was co-led by Boulder Ventures and Highpoint Ventures, with the raised funds being set aside to expand the company’s operations and business reach. Post-funding, ClinOne announced the appointment of Katherine Vandebelt and JeanMarie Markham to the company’s board. The company noted that both are Life Science leaders, who would contribute their experience and strategic insights to support the company’s planned growth.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.